M. Ferreras et al., THE INTERACTION OF STAPHYLOCOCCUS-AUREUS BICOMPONENT GAMMA-HEMOLYSINSAND LEUCOCIDINS WITH CELLS AND LIPID-MEMBRANES, Biochimica et biophysica acta. Biomembranes, 1414(1-2), 1998, pp. 108-126
Staphylococcus aureus gamma-hemolysins (HlgA, HlgB and HlgC) and Panto
n-Valentine leucocidins (LukS-PV and LukF-PV) are bi-component toxins
forming a protein family with some relationship to alpha-toxin. Active
toxins are couples formed by taking one protein from each of the two
subfamilies of the S-components (LukS-PV, HlgA and HlgC) and the F-com
ponents (LukF-PV and HlgB). We compared the mode of action of the six
possible couples on leukocytes, red blood cells and model lipid membra
nes. All couples were leucotoxic on human monocytes, whereas only four
couples (HlgA+HlgB, HlgC+HlgB, LukS-PV+HlgB and HlgA+LukF-PV) were he
molytic. Toxins HlgA+HlgB and HlgC+HlgB were also able to induce perme
abilisation of model membranes by forming pores via oligomerisation. T
he presence of membrane-bound aggregates, the smallest and most abunda
nt of which had molecular weight and properties similar to that formed
by alpha-toxin, was detected by SDS-PACE, By infrared spectroscopy in
the attenuated total reflection configuration (FTIR-ATR), the seconda
ry structure of both components and of the aggregate were determined t
o be predominantly beta-sheet and turn with small variations among dif
ferent toxins. Polarisation experiments indicated that the structure o
f the membrane complex was compatible with the formation of a beta-bar
rel oriented perpendicularly to the plane of the membrane, similar to
that of porins. The couple LukS-PV+LukF-PV was leucotoxic, but not hem
olytic. When challenged against model membranes it was able to bind to
the lipid vesicles and to form the aggregate with the beta-barrel str
ucture, but not to increase calcein permeability. Thus, the pore-formi
ng effect correlated with the hemolytic, but not with the complete leu
cotoxic activity of these toxins, suggesting that other mechanisms, li
ke the interaction with endogenous cell proteins, might also play a ro
le in their pathogenic action. (C) 1998 Elsevier Science B.V. All righ
ts reserved.